Oncology, Cardiology, Metabolic diseases, Respiratory dsystem, Diseases of the Eye, Infectious diseases, Skin, CNS, Digestive System

Novadiscovery is specialized in clinical trials, the predicting clinical efficacy of drug candidates before human trials.
In silico clinical trials are a new paradigm in our industry, de-risking drug R&D while decreasing time and cost of development. Based on
the knowledge extracted from literature and data, we build mathematical models of disease and treatment. Then, to simulate a trial, we run
those models on virtual patients to predict the clinical efficacy of new drugs at the population level. Using these techniques and workflow,
we have already helped several companies accelerate their drug development. The FDA already gave its agreement in principles for one
of our clients to entirely skip a phase II and decrease the trial size of their phase III from +10,000 to 500 patients thanks to the use of in
silico.